Directory Calendar News Careers Alumni Giving

HPM Department News

HPM alumni get together in DC

Some of our favorite HPM alumni connected at Clyde’s of Gallery Place on September 27, 2017. Back Row: Jenny Huang, Alexandra Dulin, Alex Nason, David Tye, Mark Faccenda, Kevin Broom, Mark Roberts; Front Row: Deborah Backman, Nikita Sharma, Sally Caine Leathers, Kelly Delmore, Kristin Lazzara, and Kush Banjeree. 

Hernandez on outcomes-based pricing for PCSK9 inhibitors

AMERICAN JOURNAL OF MANAGED CARE - An article by alumna INMACULADA (INMA) HERNANDEZ (HPM ’16) discusses the impact of the outcomes-based pricing arrangements proposed by Amgen on the pricing of PCSK9 inhibitor therapy, and provides recommendations for payers on the design of outcomes-based contracts. She is an assistant professor at Pitt’s School of Pharmacy. Her research explores the intersection of pharmaceutical health services and outcomes re... 

Gellad questions CVS Health move to limit access to opioid painkillers

WALL STREET JOURNAL - One of the largest managers of pharmaceutical benefits in the U.S. says it will start limiting the duration and dose of some prescriptions for opioid painkillers, in an effort to combat widespread addiction. The restrictions, based on CDC recommendations published last year, could cause some debate. WALID GELLAD, physician and HPM assistant professor, said the restrictions for chronic pain could cause cumbersome paperwork an... 

Carolinas HealthCare System names DeFurio as new CFO

CHARLOTTE BUSINESS JOURNAL - After a natioinwide search, NC-based Carolinas HealthCare System has tapped alumnus ANTHONY DEFURIO (HADM ’89) to serve as executive vice president and CFO, effective October 2017. Carolinas recently announced it would merge with Chapel Hill-based UNC Health Care, forming one of the nation’s largest hospital networks. Leading up to this new position, DeFurio was senior vice president and CFO at University of Colorado ... 

Gellad says the naloxone pricing system is out of control (video)

WTAE ACTION NEWS - As the opioid crisis sweeping the country, demand for naloxone has soared—and so has the price. HPM’s WALID GELLAD, who studies drug pricing, says the system is completely out of control. Naloxone cost increases have sky-rocketed, a huge concern for emergency service providers and community organizations. 

Gellad sceptical that drug company outcomes-based pricing can lower costs

Drug policy researcher WALID GELLAD says the outcomes-based contracts are being viewed as the solution to the drug-price problem, and they’re not going to be, at least not in the short term. The deals don’t stop drug companies from charging high starting prices for new drugs or from steadily raising prices for older drugs. Any rebates or discounts in outcomes-based contracts are off an already inflated number. He favors other ways to curb drug co... 

Accreditation president visits HPM to learn more about MHA program

Anthony Stanowski, president and CEO of the Commission of Accreditation of Healthcare Management Education (CAHME), visited the Department of Health Policy and Management on Wednesday, August 30. His main goals of the visit were to learn more about our MHA program and to stress the importance of CAHME accreditation in advancing the quality of health care management education. 

Meet Chandler Caufield (HPM '20), Dean's Scholar

Pittsburgh native and MHA/MBA student CHANDLER CAUFIELD (HPM ’20) was familiar with the city’s burgeoning medical sector buoyed by world-class hospitals and universities; however, it wasn’t until she worked in the industry that she discovered health care was the field for her. "Eventually, I landed on health care administration because it seemed like the perfect intersection of my interests and skills as well as my passion for improving the pati... 

Gellad on the cancer drug pricing firestorm

AXIOS - Doctor and health policy professor WALID GELLAD said the real question is why a potential breakthrough drug that has some question marks about effectiveness should cost more than proven life-saving measures like bone marrow or kidney transplants. “This is an amazing therapy, but there has to be a limit at which point companies can no longer charge desperate patients, or taxpayers, enormous sums.” 

Shapiro interviewed about growing better, not bigger

BECKER’S HOSPITAL REVIEW - Pitt Public Health alumnus LOU SHAPIRO (HPM ’84), CEO of the New York based Hospital for Special Surgery, talks about how he plans to stay competitive in an increasingly consolidated healthcare landscape and what it means to grow better instead of bigger. 

Hernandez says evolocumab not cost-effective at current price

TCTMD - Two new analyses call into question the cost-effectiveness of adding the PCSK9 inhibitor evolocumab to statin therapy in patients with atherosclerotic cardiovascular disease. Pitt Public Health alumna INMACULADA HERNANDEZ (HPM ’16) noted that the conclusions of the two papers are the same: the drug’s cost “is way above what we usually considered cost-effective in this country.” 

Donohue's research says hospitals could do more for survivors of opioid overdoses

NPR - Using claims data from Medicaid patients in Pennsylvania from 2008 to 2013, HPM’s JULIE DONOHUE looked at prescription opioid use and medication-assisted treatment rates before and after overdoses. The study's senior author found that “This is a time when people are vulnerable, potentially frightened by this event that’s just occurred and amenable to advice, referral, and treatment recommendations. It’s safe to characterize it as a missed o... 

HPM grad Rick Anderson guides St. Luke's hospitals through decades of change

THE MORNING CALL -- After over 30 years at the helm of St. Luke's University Health Network, RICHARD A. ANDERSON (HPM '71) is among a handful of the longest-serving top health care executives nationally. With Anderson at the helm, St. Luke's has grown from a single hospital with an annual budget of $73 million to a diversified health care organization with more than $1 billion in revenues and 9,000 employees, making it the second-biggest employer... 

Donohue on the causes of explosive growth in opioid prescription sales

HUFF POST - What caused the explosive growth in opioid sales? The FDA and TV advertising. In 1997, the FDA rules governing pharmaceutical advertising changed, allowing TV ads to name both the drug and what was for, while only naming the most significant potential side effects. After that, the number of TV ads exploded. A 2009 NPR story stated “there’s an average of 80 drug ads every hour of every day on American television. And those ads clearly ... 

Broom joins HPM leadership

UNIVERSITY TIMES - The Department of Health Policy and Management has named a new vice chair of education and director of the Master of Health Administration (MHA) and MHA/MBA joint degree programs. KEVIN BROOM comes to Pitt from Saint Louis University, where he served as an assistant professor of health management and policy. Broom succeeds WESLEY ROHRER, who returned to the HPM faculty on June 30. 

Page 8 of 22First   Previous   3  4  5  6  7  [8]  9  10  11  12  Next   Last   

Search for an Article

Share Your News

Simply click to share news of your achievements -- and those of classmates or colleagues. We're eager to hear about and share stories of student, faculty, and alumni accomplishments. Email questions to or visit

© 2018 by University of Pittsburgh Graduate School of Public Health

Login  |  Sitemap